Treatment optimization of newly diagnosed BCR-ABL positive patients with chronic myeloid leukemia (CML) in chronic phase with nilotinib vs. nilotinib plus interferon a induction and nilotinib or interferon a maintenance therapy: Interim analysis of the TIGER (CML V) study
2017
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI